Local Anesthesia Drugs Market size was over USD 3.95 billion in 2024 and is anticipated to cross USD 6.18 billion by 2037, witnessing more than 3.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of local anesthesia drugs is estimated at USD 4.07 billion.
For instance, according to the National Plastic Surgery Statistics by the American Society of Plastic Surgeons, the total cosmetic surgical procedures performed in 2020 were 2,314,720. The launch of novel and effective medications such as levobupivacaine, articaine, and ropivacaine is further expected to propel the market growth for local anesthesia medications in the upcoming years. Furthermore, in developing countries such as India, Brazil, and China, rising healthcare spending is predicted to increase the number of surgeries performed. This is likely to drive the market growth. Furthermore, as R&D investments in healthcare and pharmaceutical research increase, the efficiency of local anesthetic medications is also projected to improve.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
3.5% |
|
Base Year Market Size (2024) |
USD 3.95 billion |
|
Forecast Year Market Size (2037) |
USD 6.18 billion |
|
Regional Scope |
|
The local anesthesia drugs market is segmented based on drug type into bupivacaine, ropivacaine, lidocaine, chloroprocaine, and others. The bupivacaine segment is anticipated to grab the most significant share by the end of 2030. This can be credited to the fact that the drug provides a prolonged duration period, as it lasts significantly longer after delivery than other drugs. Furthermore, it is more effective than other medicines at controlling post-operative pain. Additionally, based on the mode of administration, the injectable segment in the market is projected to grow with a significant CAGR over the forecast period ascribing to the widespread use of injectable anesthetics in a variety of surgical procedures. On the other hand, surface anesthetics segment is expected to expand at the fastest rate in the coming years on the back of the rising advancements in the drug delivery system.
Our in-depth analysis of the global market includes the following segments:
|
Drug Type |
|
|
Application |
|
The local anesthesia drugs market is segmented into five regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa region. Asia Pacific industry is likely to account for largest revenue share by 2037, owing to high prevalence of dengue virus infections in several countries of the region such as Malaysia, Philippines and Vietnam, and the increase in government expenditure on improving healthcare infrastructure along with growing emphasis on carrying out dengue awareness campaigns in the region. According to the WHO, the population in WHO South-East Asia Region is ageing rapidly. While the proportion of people aged 60 or above was 9.8% in 2017, it will be increased to 13.7% and 20.3% by 2030 and by 2050, respectively. Furthermore, increased healthcare expenditure in the region, aided by pharmaceutical industry R&D investments, is also predicted to propel the market growth in the region. Furthermore, the market in North America is assessed to hold the largest share on the back of the the increased number of surgeries, and advances in anesthetic technologies in the region. In addition, the rising pharmaceutical expenditure to deliver effective and side-effect-free local anesthetic drugs is also evaluated to drive the market growth in the near future. For instance, according to the Congressional Budget Office (CBO) of the United States, the pharmaceutical industry devoted $83 billion to R&D expenditures in 2019.
April 2021: Pfizer announced that it had acquired an American pharmaceutical company called Amplyx Pharmaceuticals which is focused on developing therapies for diseases that affect people with weak immune systems.
March 2021: Novartis UK and Cievert, a digital health company declared a digital innovation partnership which is aimed to streamline the management of dermatological and rheumatological disorders.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?